Dave Knapp GLP-1 Industry Insider

On The Pen GLP-1 News

Health EN ↓ 198 episodi

On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 1% of all podcasts globally, and On The Pen is a top Substack best-seller.

Autore

Dave Knapp GLP-1 Industry Insider

Categoria

Health

Sito del podcast

OTPlinks.com

Ultimo episodio

8 lug 2026

Dove ascoltare?

I podcast nell'app Replaio Radio In arrivo

I podcast stanno per arrivare nell'app. Installala ora e scopri per primo un modo tutto nuovo di vivere i podcast

Scaricala su Google Play Installala gratis Android quasi 10 mln di download · valutazione 4,8 iOS in arrivo

Episodi

Dr. Spencer Nadolsky On Compound Tirzepatide After Leaving Weight Watchers 06.09.2024

Send a text Dr. Spencer Nadolsky has announced his departure from Weight Watchers and joins Dave live for a chat about Zepbound GLP1 meds and Obesity medicine. #WW #WeightWatchers #DrSpencer Visit Our Sponsor! Get Connected with Ro Body: https://www.ro.co/otp Report The Shortage: https://www.ro.co/supply-tracker Does your insurance cover GLPs? https://www.ro.com/checker VOTE!! https://www.iowapodc...

Ozempic Shortages Extended | The Weekly Dose 9.3.24 03.09.2024

Send a text Watch On The Pen Live: onthepen.tv GLP-1 News: onthepen.com SPONSOR: Ro. Co/OTP SHOW NOTES WEGOVY REDUCES COVID DEATHS https://www.wjbf.com/news/popular-weight-loss-drug-reduced-risk-of-covid-deaths-in-new-study/ WEGOVY REDUCES HEART DISEASE RISK BY 20% https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01498-3/fulltext OZEMPIC SHORTAGE TO LAST THROUGH 2024 https://www....

Zepbound Savings Card & Zepbound Vials Discussion With The Downsized 30.08.2024

Send a text Christopher and Laraine Durham of @TheDownsized join Dave to discuss the Zepbound vials arrival and the changes to the Zepbound savings card! Visit Our Sponsor! Get Connected with Ro Body: https://www.ro.co/otp Report The Shortage: https://www.ro.co/supply-tracker Does your insurance cover GLPs? https://www.ro.com/checker VOTE!! https://www.iowapodcastawards.com/vote WAYS TO SUPPORT: V...

Massive Zepbound Vials News 8.27.24 27.08.2024

Send a text RO TOOLS TO HELP YOU: Ro Body: ro.co/otp #ReportTheShortage - ro.co/supply-tracker #OptInForObesity - See if you're covered ro.co/checker Madison Muller Article on Zepbound Vial Pricing: https://www.bloomberg.com/news/articles/2024-08-27/eli-lilly-is-now-selling-zepbound-weight-loss-drug-at-50-discount?srnd=undefined Search Zepbound Pricing: https://www.goodrx.com/zepbound/what-is...

On The Pen: The Weekly Dose 8.20.24 19.08.2024

Send a text VOTE FOR THE WEEKLY DOSE PODCAST! CHECK OUT OUR SPONSOR: RO.CO/OTP Semaglutide in Parkinsons and Opiod Abuse https://www.wired.com/story/the-benefits-of-ozempic-are-multiplying/? How Roche Passed on Orforglipron https://www.swissinfo.ch/eng/multinational-companies/how-roche-passed-on-a-potential-14bn-a-year-weight-loss-pill/86877239?fbclid=IwZXh0bgNhZW0CMTEAAR1doDlsWIFXuUJYA9Kz75D9VvzZ...

On The Pen: The Weekly Dose 8.13.24 13.08.2024

Send a text # ReleaseTheVials https://www.onthepen.com/post/eli-lilly-to-releasethevials-of-zepbound Eli Lilly has released single-dose vials for ZepBound to stabilize higher dose supplies and removed all Mounjaro and ZepBound doses from the FDA shortage list, though tirzepatide remains in shortage. Novo Nordisk is seeking FDA approval for Icosema, a combination of insulin and semaglutide, with a...

On The Pen: The Weekly Dose 8.6.24 06.08.2024

Send a text Fortune interview: https://fortune.com/2024/08/02/eli-lilly-mounjaro-zepbound-weight-loss-ceo-alzheimers-drug/ Tirzepatide shortages (viral tiktok video with 199,000+ views): https://www.onthepen.com/post/zepbound-and-mounjaro-shortages-are-over-what-this-means-for-compounds https://cdernextgenportal.fda.gov/publicportal/s/dsm-submission https://www.reuters.com/business/healthcare-phar...

On The Pen: The Weekly Dose 7.30.24 30.07.2024

Send a text Book Email Alerts: https://www.onthepen.com/glp1-book Altimmune https://ir.altimmune.com/news-releases/news-release-details/altimmune-announces-publication-clinical-study-pemvidutide Novo Nordisk Expansion: https://www.fiercepharma.com/pharma/amid-wegovy-and-ozempic-boom-novo-eyes-new-facility-200-acre-land-buy-denmark Novo Nordisk Fire: https://www.thelocal.dk/20240724/danish-emergenc...

On The Pen: The Weekly Dose 7.23.24 22.07.2024

Send a text On The GLP-1 Pen Book Alerts: https://onthepen.com/emails Gan & Lee (China) https://www.prnewswire.com/news-releases/gan--lee-pharmaceuticals-bi-weekly-twice-a-month-glp-1-receptor-agonist-gzr18-injection-achieved-17-29-weight-loss-at-30-weeks-in-a-phase-iib-clinical-trial-302202575.html Mazdutide (China): https://www.fiercebiotech.com/biotech/innovent-bags-another-phase-3-win-next...

On The Pen: The Weekly Dose 7.16.24 15.07.2024

Send a text PBM reform in Illinois (tiktok video) https://x.com/ManOnMounjaro/status/1812833885375332394 FTC on PBM https://www.ftc.gov/system/files/ftc_gov/pdf/pharmacy-benefit-managers-staff-report.pdf https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen FDA and social media (tiktok video) https://news.bloomberglaw.com/health-l...

Amylin and the future of obesity medicine with Dr. Beverly Tchang 13.07.2024

Send a text Dave chats with world renowned obesity expert who consults for the likes of Novo Nordisk! Beverly Tchang, MD is a triple board-certified physician  with a focus on obesity medicine. Since 2018, she has been treating patients and training professionals in endocrinology and obesity. Her nationally recognized expertise has led her to extend her knowledge and experience as an advisor to  c...

On The Pen: The Weekly Dose 7.9.24 08.07.2024

Send a text Ozempic reduces cancer risk: https://www.bloomberg.com/news/articles/2024-07-05/ozempic-may-lower-risk-of-obesity-related-cancers-study-finds Semaglutide correlated with blindness (tiktok video): https://www.statnews.com/2024/07/03/ozempic-wegovy-naion-vision-loss-study 15-years as type-2 diabetic results in a 78% chance of have some degree of retinal eye damage https://www.webmd.com/d...

On The Pen: The Weekly Dose 7.2.24 02.07.2024

Send a text Get OTP Emails: https://www.onthepen.com/emails Eli Lilly Eli Lilly sent cease and desist letters to providers of research grade GLP-1s Exclusive news from onthepen.com that has not been covered by any other source https://www.onthepen.com/post/generic-versions-of-zepbound-how-recent-news-affects-their-future Him & Hers: Him & Hers giving GLP medications without consulting with...

On The Pen: The Weekly Dose 6.25.24 25.06.2024

Send a text Novo Nordisk expansion in the US: https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=168528 Generic liraglutide https://www.onthepen.com/post/teva-launches-first-ever-generic-glp-1-a-game-changer-for-diabetes-and-weight-management New Wegovy Coupon: https://www.wegovy.com/coverage-and-savings/save-on-wegovy.html New Mounjaro Card (tiktok video) https:...

On The Pen: The Weekly Dose 6.18.24 18.06.2024

Send a text PBM Reform Form Letter:  Link to the Letter: https://www.onthepen.com/post/pbm-reform-form-letter-for-elected-representatives Express scripts (tiktok video on PBM reform): Link to my video: https://www.youtube.com/watch?v=l0g6RwViOxc Michigan (tiktok video) Link (Madison Muller): https://www.bloomberg.com/news/articles/2024-06-12/michigan-s-largest-insurer-to-drop-weight-loss-drug-cove...

Zepbound And Liver Disease 12.06.2024

Send a text Eli Lilly's phase 2 SYNERGY-NASH study shows tirzepatide effectively resolves MASH and improves fibrosis, offering hope for millions. Read more here: https://www.onthepen.com/post/tirzepatide-shows-promise-in-treating-mash-key-findings-from-the-synergy-nash-study Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%! 🤝 Visit Our Sponsors! OTPLinks.com Decoding GLP-1 B...

On The Pen: The Weekly Dose 6.11.24 11.06.2024

Send a text Ro.co/supply-tracker FDA shortage update (tiktok video): Link: https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm? AI=Tirzepatide%20Injection&st=c EASL (European Association for the Study of the Liver) 2024 in Milan Italy Link: https://investor.lilly.com/news-releases/news-release-details/lillys-tirzepatide-was-superior-placebo-mash-resolution-and-...

On The Pen: The Weekly Dose 6.4.24 04.06.2024

Send a text https://ro.co/weight-loss/supply-tracker https://www.youtube.com/watch?v=mL_krAas70k Novo Nordisk Advertising: Novo Nordisk launches new advertising campaign "The Power of Wegovy" This advertisement includes the new indication for reduction of cardiovascular risk For 2023, the #5 advertising spend for a drug was Rybelsus at $191 million.  The #6 advertising spend was Ozempic...

OTP EPS 68: Ro CEO Zach Reitano Talks GLP-1 Supply Tracker 31.05.2024

Send a text Zachariah Reitano is the founder of Ro, a telehealth company that has a vision of giving consumers more power over their health, he joins #OnThePen to talk all things #mounjaro #zepbound #wegovy #ozempic  Reitano is the founder of Ro, a telehealth company that has a vision of giving consumers more power over their health. https://ro.co/weight-loss/supply-tracker/ Visit TRYSHED.COM to l...

On The Pen: The Weekly Dose 5.28.24 28.05.2024

Send a text On The Pen News: https://www.onthepen.com/blog SHOW NOTES: Ozempic study in New England Journal of Medicine: Link: https://www.bloomberg.com/news/articles/2024-05-24/novo-s-ozempic-slashes-risk-of-death-in-kidney-disease-study Compounding (tiktok video) Link: https://www.abc.net.au/news/2024-05-22/compound-pharmacies-banned-weight-loss-drugs-replica-ozempic/103861108 Zealand Pharma: Li...

On The Pen Live Eps 67: Survodutide Trial Participant Tells All! 25.05.2024

Send a text In this week’s episode of On The Pen Live, guest Scott Liberto of PlanetScott.com joins to discuss his experience in the Survodutide clinical trial. Survodutide is an investigational dual agonist targeting both the glucagon and GLP-1 receptors, developed by Boehringer Ingelheim in collaboration with Zealand Pharma. This novel drug is designed to treat obesity and metabolic dysfunction-...

On The Pen: The Weekly Dose 5.21.24 21.05.2024

Send a text 📧 SIGN UP FOR EMAILS: https://www.onthepen.com/emails 💳 BECOME A MEMBER: Join this channel https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join 📰 SEEKING ALPHA ARTICLE: https://seekingalpha.com/news/4092598-tiktok-restrict-weight-loss-drug-promotion 🎙️PODCAST LINK: https://podcasts.apple.com/us/podcast/on-the-pen-the-weekly-dose/id1725737068 💵 DONATIONS: Venmo: https://ven...

On The Pen: The Weekly Dose 5.14.24 14.05.2024

Send a text MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo: OnThePen Ca$h App: ManOnMounjaro Hello Fresh Free Box: https://www.hellofresh.com/pages/raf_lp11?c=FIH-XR3LF83PJ9QE&utm_campaign=referralinvite&utm_medium=clipboard&utm_source=freebies&utm_invitername=David&utm_term=web&discount_comm_id=9...

Threats to Lilly's Zepbound & Mounjaro Printing Press 11.05.2024

Send a text Roche Pharmaceuticals has acquired Carmot Therapeutics along with three obesity and type 2 diabetes candidates: CT-868 / CT-368 / CT-986 MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo: OnThePen Ca$h App: ManOnMounjaro Hello Fresh Free Box: https://www.hellofresh.com/pages/raf_lp11?c=FIH-XR3LF83PJ9QE&utm_c...

On The Pen: The Weekly Dose 5.7.24 08.05.2024

Send a text MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join  Venmo: OnThePen  Ca$h App: ManOnMounjaro  SOCIAL LINKS  https://www.tiktok.com/@manonthemounjaro  https://twitter.com/ManOnMounjaro  https://instagram.com/manonthemounjaro  https://facebook.com/manonthemounjaro  #Zepbound #Maritide #mounjaro  LINKS  Life Update Blog:...

Ascolta il podcast On The Pen GLP-1 News su Replaio

Radio e podcast in un'unica app - gratis e senza registrazione. Installala oggi e non perderti il lancio

Scaricala su Google Play

Replaio non è un editore di podcast; i nomi dei programmi, le copertine e l'audio appartengono ai rispettivi autori e vengono distribuiti tramite feed RSS pubblici